The Longevity Drug Thousands Are Taking Off-Label: What Science Really Says About Rapamycin

Low-dose rapamycin has extended lifespan in mice more consistently than any other compound. The first major human trial completed in 2025. Here is an honest, evidence-based account of what we know — and the significant gap that still exists.

This story was reported by Medical Daily. EUROPES curates Europe's most relevant coverage — read the full report at the original source.